La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Viracta Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Viracta Therapeutics..

Viracta Therapeutics (NASDAQ:VIRX) Azioni, Catena delle Opzioni

Viracta Therapeutics

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Viracta Therapeutics, Inc. - Common Stock

Viracta Therapeutics Inc

The <a href="https://www.benzinga.com/personal-finance/24/10/41438273/can-you-guess-how-much-money-the-fat-fire-movement-says-you-need-to-retire-early-heres-a-hint-it">Financial Independence Retire Early (FIRE) movement</a> has captured attention across generations. It promises a life where financial independence allows you to retire early and focus on what you love. But not everyone is a fan. Financial expert Suze Orman has been famously critical of FIRE, labeling it dangerous for those without substantial wealth.
Don't Miss:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/100k-cd">$100K Sitting In A CD Account, Should I Move Money Into The Stock Market?</a></li>
</ul>
The FIRE movement is rooted in two main ideas: extreme saving and early retirement. By saving 50% or more of their income, followers of FIRE aim to accumulate a large retirement fund to live off investment returns, <a href="https://www.benzinga.com/personal-finance/24/08/40491347/47-year-old-unmotivated-multimillionaire-doctor-asks-dave-ramsey-retire-now-or-work-13-more-year">often before age 40</a>. While some adhere to "lean FIRE," maintaining a modest lifestyle with a smaller retirement fund, others pursue "fat FIRE," accumulating more to enjoy a comfortable lifestyle. The concept has gained significant traction, especially among millennials seeking alternatives to traditional career paths.
However, orman believes that FIRE oversimplifies the financial risks involved. In a 2018 interview on the Afford Anything podcast, she warned that even a seemingly substantial nest egg, like $2 million, might not be enough.&nbsp;
Trending: Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a>
"$2 million is nothing. It's nothing. It's pennies in today's world, to tell you the truth," she stated, expressing her concern that even millions could fall short in the face of life's uncertainties. Orman explained, "If a catastrophe happens … what are you going to do? You are going to burn up alive." For her, retirement requires far more planning than what many anticipate.&nbsp;
Orman's perspective is deeply rooted in the belief that financial independence requires a far larger cushion than most people realize. She even made a clear distinction between <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">average savers and the ultra-wealthy</a>. "If you have $20 [million], $40 [million], $50 [million] or $100 million, be like me, okay," Orman said. "If you have that kind of money … and want to retire, fine." But for the vast majority, she warns, retiring without that level of wealth is risky and could lead to financial disaster. Her message was simple: early retirement might not be safe unless you&#8217;re extraordinarily wealthy.
Trending: This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.
Orman's core criticism revolves around FIRE's approach to risk. She points out that unexpected expenses – like major health issues or long-term care – can devastate savings, especially for those who retire decades early. Orman illustrated the potential costs by suggesting that supporting a disabled family member could easily require $250,000 a year. Coupled with living expenses, she argues that maintaining a safe, sustainable retirement could require as much as $10 million in savings to ensure a comfortable life through any storms that might come.
With inflation steadily increasing, her projections from 2018 seem even more relevant now. Living costs, health care expenses and potential tax hikes have all risen, making financial independence harder to achieve than just a few years ago.
See Also: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Ultimately Orman advises that the risk of retiring early outweighs the reward if you're not <a href="https://www.benzinga.com/personal-finance/24/10/41125098/suze-orman-says-the-personal-finance-of-americans-is-really-really-bad-even-though-the-stock-mar">financially equipped for unforeseen hardships</a>. "If you don't have at least $5 million or $10 million, don't retire early," she emphasized. In her view, early retirement might work for those with vast resources – people who, like herself, have tens of millions to safeguard against all possibilities – but for everyone else, it's a path that could lead to financial ruin rather than freedom.
So, is FIRE worth pursuing? It depends on your risk tolerance, lifestyle goals and financial resilience.&nbsp;
The <a href="https://www.benzinga.com/personal-finance/24/09/40964924/most-people-expect-to-retire-at-67-but-56-retire-sooner-can-you-guess-the-actual-average-retirem">average retirement age</a> is 62, but Orman strongly advocates working longer and <a href="https://www.benzinga.com/personal-finance/24/05/39064579/suze-orman-says-70-is-the-new-retirement-age-but-is-she-right">delaying Social Security until 70</a> to maximize those benefits. <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">Consulting with a financial advisor could be one of the smartest moves</a> for anyone eyeing an early exit from work. An advisor can help you stress-test your retirement plan, look at real-life scenarios and ensure you're prepared for whatever may come.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>According to Vanguard&#8217;s Advisor&#8217;s Alpha Study, working with a financial advisor can result in approximately 3% higher net returns annually,<a href="https://www.benzinga.com/money/3-percent-advantage-financial-advisor"> here are the benefits of partnering with a financial advisor and how to find the right one near you in minutes.</a></li>
</ul>

Personal Finance

Suze Orman Says If You're Rich 'Like Her' Then You Can Retire Early – But If You Only Have $2 Million Saved: 'You'll Burn Up Alive'

TD Cowen analyst Dan Brennan maintains Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Hold and lowers the price target from $72 to $70.

News

Price Target

Analyst Ratings

BRKR

TD Cowen Maintains Hold on Bruker, Lowers Price Target to $70

Roth MKM analyst Chip Moore maintains Hyster Yale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HY#NYSE">HY</a>) with a Buy and lowers the price target from $84 to $70.

Roth MKM Maintains Buy on Hyster Yale, Lowers Price Target to $70

Honda Motor Company, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMC#NYSE">HMC</a>) shares are trading lower on Wednesday following a decline in the first-half profit and reduced <a href="https://global.honda/en/investors/library/documents/main/00/teaserItems3/00/linkList/00/link/FYE202503_2Q_financial_presentation_e_1.pdf" target="_blank" rel="noreferrer noopener">annual </a>profit forecast.
The company reported the first half of FY24 revenue growth of 12.4% year over year 10.798 trillion yen ($69.9 billion), while profits declined 19.7% to 494.6 billion Yen ($3.20 billion).
Automobile consolidated unit sales rose by 64,000 units, driven by strong ICE/HEV sales and the full-scale launch of <a target="_blank" href="https://global.honda/en/investors/library/documents/main/00/teaserItems3/00/linkList/03/link/FYE202503_2Q_financial_presentation_script_e.pdf" rel="noreferrer noopener">EVs </a>in North America.
However, group unit sales fell by 155,000 units, primarily due to lower sales in China.
In the motorcycle business, global sales remained robust, reaching a cumulative total of 10 million units by the end of the second quarter.
Operating profit rose 6.6% to 742.6 billion yen, with a margin of 6.9% (vs<a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">. 7.2% in the first half of FY23)</a>.
Additionally, a resolution was made at the company&#8217;s board meeting to repurchase company shares, up to 100 billion yen.
Outlook: For FY25, the company reduced profit for the year attributable to owners of the parent by 50 billion yen to 950 billion yen due to lower equity method profit from reduced sales in China and decreased profit in <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">Honda&#8217;s affiliates in Japan</a>.
On the other hand, the company raised the sales revenue forecast by 700 billion yen to 21.000 trillion yen.
Meanwhile, Honda reiterated its FY25 operating profit forecast at 1.420 trillion yen.
Price Action: HMC shares are down 9.72% at $27.36 at the last check Wednesday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41699452/hondas-pickup-beats-tesla-cybertruck-as-most-american-made-truck" target="_blank" rel="noreferrer noopener">Honda&#8217;s Pickup Beats Tesla Cybertruck As Most American Made Truck</a></li>
</ul>

Earnings

Equities

Large Cap

Movers

Honda Reports 19.7% Profit Decline in H1, Lowers Annual Profit Forecast Amid China Sales Slump

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Hold and lowers the price target from $132 to $122.

BNTX

TD Cowen Maintains Hold on BioNTech, Lowers Price Target to $122

Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>) with a Buy and lowers the price target from $95 to $75.

EXAS

Canaccord Genuity Maintains Buy on Exact Sciences, Lowers Price Target to $75

Donald Trump has been elected as the 47th president of the U.S., and the future of <a href="https://www.benzinga.com/electric-vehicles">the electric vehicle (EV) industry</a> is uncertain. 
Here's a look at how the president-elect&#8217;s policy changes could affect<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41755274/trump-win-could-hinder-tech-ev-sector-growth-slow-the-pace-of-ai-revolution-analyst"> EV makers in the US. </a>
Trump's EV Views: Trump, who <a href="https://www.benzinga.com/markets/equities/24/10/41562048/leonardo-dicaprio-backs-harris-says-trump-continues-to-deny-the-facts-on-climate">has denied climate change</a>, as largely condemned EVs. He claims they will cost autoworkers' jobs as factories make the shift to electric vehicles. He has also said EVs are<a href="https://www.benzinga.com/news/24/07/39854007/trump-says-he-will-end-the-electric-vehicle-mandate-on-day-one-days-after-tesla-ceo-elon-musks-endor"> being forced </a>on consumers through unfair regulations. 
"I will end the electric vehicle mandate on day one, thereby saving the auto industry from complete obliteration which is happening right now and saving US customers thousands and thousands of dollars per car," Trump said in a speech at the Republican National Convention in July.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/24/11/41754367/china-escalates-trade-dispute-lodges-complaint-with-wto-over-european-ev-tariffs">China Escalates Trade Dispute, Lodges Complaint With WTO Over European EV Tariffs</a>
Trump has also said he plans <a href="https://www.benzinga.com/news/24/07/39854007/trump-says-he-will-end-the-electric-vehicle-mandate-on-day-one-days-after-tesla-ceo-elon-musks-endor">to eliminate</a> many vehicle emissions standards under the Environmental Protection Agency as well as many EV incentives included in the Biden administration's Inflation Reduction Act (IRA).
Analysts Weigh In: Wedbush analysts, including Dan Ives, see <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41755274/trump-win-could-hinder-tech-ev-sector-growth-slow-the-pace-of-ai-revolution-analyst">trouble ahead</a> for the EV industry.&nbsp;
&#8220;We believe a Trump presidency would be an overall negative for the EV industry as likely the EV rebates/tax incentives get pulled, however for Tesla we see this as a potential positive with some caveats,&#8221; the Wedbush analysts wrote.&nbsp;
The analysts pointed to Tesla, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) profitability, along with the company's size and scale, as advantages over its competitors who may struggle after losing rebates and tax incentives. Wedbush also sees Tesla benefiting from higher import fees on Chinese EVs under a Trump administration. 
&#8220;Higher China tariffs that would continue to push away cheaper EV players (BYD, Nio, etc.) from flooding the US market over the coming years,&#8221; Wedbush wrote.&nbsp;
Tesla CEO Elon Musk, who campaigned heavily <a href="https://www.benzinga.com/news/24/11/41766808/mark-cuban-congratulates-trump-musk-before-the-election-is-called-says-they-won-fair-and-square">for the GOP leader</a>, acknowledged that a Trump presidency would likely mean the end of EV subsidies and tax credits during Tesla's second-quarter earnings call. 
The impact would be slight for Tesla and devastating for its competitors, Musk said.
"But long term probably actually helps Tesla, would be my guess, yes," Musk said.&nbsp;
The Big 3: Legacy automakers, General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) are struggling as they transition from traditional combustion engines to EVs. 
The Big 3 automakers have recently announced they will delay investments and other plans related to the production of EVs amid <a href="https://www.benzinga.com/news/24/11/41737069/ford-ev-sales-drop-over-8-in-october-as-demand-for-f-150-lightning-slows-down">waning demand </a>from consumers. 
What's Next: It remains to be seen what measures will be repealed under a Trump administration and how each automaker will be affected. However, investors seem to agree with Tesla analysts that Trump's second term is a positive catalyst for the EV giant. Tesla shares are soaring 12.8% higher at $283.49 at the time of publication Wednesday, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a></li>
</ul>
Image: Shutterstock

Politics

STLA

TSLA

What Does Trump's Victory Mean For EV Giant Tesla And The Big 3 Automakers?

Roth MKM analyst Bill Kirk maintains Grocery Outlet Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) with a Neutral and lowers the price target from $20 to $16.

Roth MKM Maintains Neutral on Grocery Outlet Holding, Lowers Price Target to $16

Roth MKM analyst Jason Wittes reiterates Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) with a Buy and maintains $100 price target.

Reiteration

GMED

Roth MKM Reiterates Buy on Globus Medical, Maintains $100 Price Target

For Kevin O&#8217;Leary, the business world is black and white: you either succeed or fail. "Business is binary. There are winners and losers. You either make money or you don't," he says.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Business is binary. There are winners and losers. You either make money or you lose it. If you want to succeed in business you have to work 25hrs a day because there's someone across the world who will kick your a&#x2A;s if you don't. <a href="https://t.co/mRURSOPoz8">pic.twitter.com/mRURSOPoz8</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1853432280565330223?ref_src=twsrc%5Etfw">November 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
O&#8217;Leary, famously known as &#8220;Mr. Wonderful&#8221; on Shark Tank, loves sharing his formula for success, especially with young entrepreneurs. His advice is direct: if you&#8217;re in your 20s and trying to build a business, forget about having a work-life balance. The competition is just too intense.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
&#8220;You're competing with people in Mumbai or Shanghai who are <a href="https://www.benzinga.com/startups/24/10/41231722/kevin-oleary-says-theres-no-worklife-balance-for-new-entrepreneurs-as-guys-in-mumbai-or-shanghai-wor">willing to work 24 hours a day</a>, eight days a week,&#8221; O&#8217;Leary once said. In his view, you&#8217;re at risk of being left behind unless you&#8217;re ready to put in those kinds of hours. He even goes so far as to say that to be successful, you need to work relentlessly or as he puts it, &#8220;25 hours a day.&#8221;&nbsp;
Working around the clock sounds extreme to most people, but O&#8217;Leary knows the importance of laying a strong foundation in the early stages of your career. When you're young, you have the time and energy to make sacrifices because &#8220;In your 20s, you can afford the time, the focus and all the stress that comes with building something from the ground up. You should start thinking about taking some time off only after establishing that foundation.&#8221;
Trending: With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today.</a>
O&#8217;Leary knows firsthand how frustrating it can be to slow down. After selling The Learning Company, he was <a href="https://www.benzinga.com/startups/24/09/40776473/it-was-boring-kevin-oleary-explored-every-beach-on-earth-after-he-first-got-rich-but-the-highs-and-l?utm_campaign=partner_feed&amp;utm_source=yahooFinance&amp;utm_medium=partner_feed&amp;utm_content=site&amp;nid=41231722">tied up in a noncompete agreement</a> that kept him out of the software industry for three years. What many might see as a well-earned break was stifling for O&#8217;Leary, who said he felt &#8220;stale&#8221; without the ability to work. He quickly understood that his feeling of purpose depended on his ability to continue building businesses.
This relentless pursuit of success is also reflected in his approach to investing. O&#8217;Leary has one rule regarding money: always invest in information. &#8220;If you make decisions without relevant information, I guarantee you, you will lose money 100% of the time,&#8221; he said.&nbsp;
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Each day, <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/01/30554489/kevin-oleary-reveals-his-secret-to-success-what-he-does-every-day-to-avoid-losing-money-">O&#8217;Leary starts his mornings early</a>, dedicating an hour to consuming news from various sources – early broadcasts from Europe and Asia or academic and financial research.
For O&#8217;Leary, the lesson is straightforward: Sacrifice is necessary for success. To succeed as an entrepreneur, you must be prepared to work harder and longer hours than your competitors, stay informed and persevere.
Read Next:
<ul>
<li>‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a></li>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's an opportunity to invest at $1,000 for only $0.50/share today.</a></li>
</ul>

Startups

Kevin O'Leary Claims 'You Have To Work 25 Hours A Day.' For Him, Business Is Simple: 'You Either Make Money Or You Don't'

WIIM

CRCT

Cricut shares are trading lower after the company cut its price target on the stock from $6.5 to $5.75.

Roth MKM analyst Sean McGowan maintains ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) with a Buy and raises the price target from $6 to $8.

CDXC

Roth MKM Maintains Buy on ChromaDex, Raises Price Target to $8

Dine Brands Global shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$250.00</td>
<td>$107.0K</td>
<td>4.1K</td>
<td>12.4K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$72.50</td>
<td>$98.4K</td>
<td>3.7K</td>
<td>7.4K</td>
</tr>
<tr>
<td>BX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$180.00</td>
<td>$1.4 million</td>
<td>654</td>
<td>5.5K</td>
</tr>
<tr>
<td>MS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$70.0K</td>
<td>10</td>
<td>3.2K</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$29.00</td>
<td>$29.9K</td>
<td>233</td>
<td>2.1K</td>
</tr>
<tr>
<td>KKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$100.00</td>
<td>$131.5K</td>
<td>3.4K</td>
<td>260</td>
</tr>
<tr>
<td>BLK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1000.00</td>
<td>$407.5K</td>
<td>4</td>
<td>100</td>
</tr>
<tr>
<td>RJF</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$170.00</td>
<td>$40.0K</td>
<td>16</td>
<td>100</td>
</tr>
<tr>
<td>TFC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$35.00</td>
<td>$94.5K</td>
<td>2.0K</td>
<td>80</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$500.00</td>
<td>$34.7K</td>
<td>1.6K</td>
<td>31</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on November 8, 2024. Parties traded 214 contract(s) at a $250.00 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $107.0K, with a price of $500.0 per contract. There were 4138 open contracts at this strike prior to today, and today 12429 contract(s) were bought and sold. 
• Regarding C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we observe a call option sweep with bullish sentiment. It expires in 44 day(s) on December 20, 2024. Parties traded 639 contract(s) at a $72.50 strike. This particular call needed to be split into 28 different trades to become filled. The total cost received by the writing party (or parties) was $98.4K, with a price of $154.0 per contract. There were 3795 open contracts at this strike prior to today, and today 7475 contract(s) were bought and sold. 
• For BX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), we notice a call option sweep that happens to be bullish, expiring in 135 day(s) on March 21, 2025. This event was a transfer of 1240 contract(s) at a $180.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $1.4 million, with a price of $1150.0 per contract. There were 654 open contracts at this strike prior to today, and today 5551 contract(s) were bought and sold. 
• For MS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), we notice a put option sweep that happens to be bullish, expiring in 72 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $135.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $70.0K, with a price of $700.0 per contract. There were 10 open contracts at this strike prior to today, and today 3256 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a put option sweep with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 113 contract(s) at a $29.00 strike. This particular put needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $29.9K, with a price of $265.0 per contract. There were 233 open contracts at this strike prior to today, and today 2178 contract(s) were bought and sold. 
• For KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), we notice a call option sweep that happens to be bearish, expiring in 317 day(s) on September 19, 2025. This event was a transfer of 23 contract(s) at a $100.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $131.5K, with a price of $5720.0 per contract. There were 3464 open contracts at this strike prior to today, and today 260 contract(s) were bought and sold. 
• Regarding BLK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>), we observe a put option trade with bearish sentiment. It expires in 436 day(s) on January 16, 2026. Parties traded 50 contract(s) at a $1000.00 strike. The total cost received by the writing party (or parties) was $407.5K, with a price of $8150.0 per contract. There were 4 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• Regarding RJF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>), we observe a call option trade with bearish sentiment. It expires in 191 day(s) on May 16, 2025. Parties traded 50 contract(s) at a $170.00 strike. The total cost received by the writing party (or parties) was $40.0K, with a price of $800.0 per contract. There were 16 open contracts at this strike prior to today, and today 100 contract(s) were bought and sold. 
• For TFC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>), we notice a call option trade that happens to be bullish, expiring in 226 day(s) on June 20, 2025. This event was a transfer of 80 contract(s) at a $35.00 strike. The total cost received by the writing party (or parties) was $94.5K, with a price of $1182.0 per contract. There were 2070 open contracts at this strike prior to today, and today 80 contract(s) were bought and sold. 
• Regarding MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we observe a call option trade with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 11 contract(s) at a $500.00 strike. The total cost received by the writing party (or parties) was $34.7K, with a price of $3162.0 per contract. There were 1606 open contracts at this strike prior to today, and today 31 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

COIN

HOOD

10 Financials Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$300.00</td>
<td>$41.2K</td>
<td>34.6K</td>
<td>109.6K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$210.00</td>
<td>$37.6K</td>
<td>46.8K</td>
<td>38.8K</td>
</tr>
<tr>
<td>DHI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$170.00</td>
<td>$49.4K</td>
<td>11.4K</td>
<td>9.0K</td>
</tr>
<tr>
<td>MBLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$12.00</td>
<td>$353.4K</td>
<td>2.8K</td>
<td>2.3K</td>
</tr>
<tr>
<td>DKS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$195.00</td>
<td>$50.1K</td>
<td>828</td>
<td>1.3K</td>
</tr>
<tr>
<td>PRKS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$55.00</td>
<td>$38.8K</td>
<td>181</td>
<td>1.1K</td>
</tr>
<tr>
<td>EWCZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.50</td>
<td>$33.6K</td>
<td>2.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>W</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$42.00</td>
<td>$28.5K</td>
<td>1.0K</td>
<td>674</td>
</tr>
<tr>
<td>TOL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$150.00</td>
<td>$60.4K</td>
<td>183</td>
<td>639</td>
</tr>
<tr>
<td>BBY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$93.00</td>
<td>$48.1K</td>
<td>486</td>
<td>377</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be bullish, expiring in 2 day(s) on November 8, 2024. This event was a transfer of 200 contract(s) at a $300.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $41.2K, with a price of $206.0 per contract. There were 34669 open contracts at this strike prior to today, and today 109633 contract(s) were bought and sold. 
• For AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we notice a call option sweep that happens to be bearish, expiring in 9 day(s) on November 15, 2024. This event was a transfer of 200 contract(s) at a $210.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $37.6K, with a price of $188.0 per contract. There were 46810 open contracts at this strike prior to today, and today 38848 contract(s) were bought and sold. 
• Regarding DHI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>), we observe a call option sweep with bullish sentiment. It expires in 9 day(s) on November 15, 2024. Parties traded 494 contract(s) at a $170.00 strike. This particular call needed to be split into 44 different trades to become filled. The total cost received by the writing party (or parties) was $49.4K, with a price of $100.0 per contract. There were 11450 open contracts at this strike prior to today, and today 9078 contract(s) were bought and sold. 
• Regarding MBLY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>), we observe a call option trade with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 789 contract(s) at a $12.00 strike. The total cost received by the writing party (or parties) was $353.4K, with a price of $448.0 per contract. There were 2854 open contracts at this strike prior to today, and today 2332 contract(s) were bought and sold. 
• Regarding DKS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>), we observe a put option trade with bearish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 30 contract(s) at a $195.00 strike. The total cost received by the writing party (or parties) was $50.1K, with a price of $1670.0 per contract. There were 828 open contracts at this strike prior to today, and today 1352 contract(s) were bought and sold. 
• For PRKS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>), we notice a call option sweep that happens to be bearish, expiring in 44 day(s) on December 20, 2024. This event was a transfer of 105 contract(s) at a $55.00 strike. This particular call needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $38.8K, with a price of $370.0 per contract. There were 181 open contracts at this strike prior to today, and today 1108 contract(s) were bought and sold. 
• Regarding EWCZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>), we observe a call option sweep with bearish sentiment. It expires in 44 day(s) on December 20, 2024. Parties traded 369 contract(s) at a $7.50 strike. This particular call needed to be split into 33 different trades to become filled. The total cost received by the writing party (or parties) was $33.6K, with a price of $90.0 per contract. There were 2181 open contracts at this strike prior to today, and today 1000 contract(s) were bought and sold. 
• Regarding W (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), we observe a put option sweep with bullish sentiment. It expires in 9 day(s) on November 15, 2024. Parties traded 76 contract(s) at a $42.00 strike. This particular put needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $28.5K, with a price of $375.0 per contract. There were 1033 open contracts at this strike prior to today, and today 674 contract(s) were bought and sold. 
• Regarding TOL (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>), we observe a put option trade with bullish sentiment. It expires in 135 day(s) on March 21, 2025. Parties traded 42 contract(s) at a $150.00 strike. The total cost received by the writing party (or parties) was $60.4K, with a price of $1440.0 per contract. There were 183 open contracts at this strike prior to today, and today 639 contract(s) were bought and sold. 
• Regarding BBY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>), we observe a put option sweep with bullish sentiment. It expires in 2 day(s) on November 8, 2024. Parties traded 125 contract(s) at a $93.00 strike. This particular put needed to be split into 27 different trades to become filled. The total cost received by the writing party (or parties) was $48.1K, with a price of $385.0 per contract. There were 486 open contracts at this strike prior to today, and today 377 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

EWCZ

MBLY

PRKS

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$145.00</td>
<td>$30.2K</td>
<td>59.8K</td>
<td>115.2K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$20.00</td>
<td>$61.8K</td>
<td>19.9K</td>
<td>16.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$200.00</td>
<td>$55.2K</td>
<td>128.8K</td>
<td>14.8K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$65.00</td>
<td>$31.3K</td>
<td>7.7K</td>
<td>3.2K</td>
</tr>
<tr>
<td>ZS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$160.00</td>
<td>$2.2 million</td>
<td>1.1K</td>
<td>3.1K</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$170.00</td>
<td>$146.4K</td>
<td>9.4K</td>
<td>2.2K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$45.00</td>
<td>$100.3K</td>
<td>3.3K</td>
<td>1.2K</td>
</tr>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$57.00</td>
<td>$37.2K</td>
<td>1.6K</td>
<td>711</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$230.00</td>
<td>$30.0K</td>
<td>1.6K</td>
<td>578</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$170.00</td>
<td>$66.1K</td>
<td>3.3K</td>
<td>467</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on November 8, 2024. Parties traded 159 contract(s) at a $145.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.2K, with a price of $190.0 per contract. There were 59807 open contracts at this strike prior to today, and today 115290 contract(s) were bought and sold. 
• Regarding MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we observe a call option trade with bullish sentiment. It expires in 9 day(s) on November 15, 2024. Parties traded 711 contract(s) at a $20.00 strike. The total cost received by the writing party (or parties) was $61.8K, with a price of $87.0 per contract. There were 19906 open contracts at this strike prior to today, and today 16286 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bullish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 20 contract(s) at a $200.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $55.2K, with a price of $2760.0 per contract. There were 128880 open contracts at this strike prior to today, and today 14851 contract(s) were bought and sold. 
• Regarding PLTR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>), we observe a call option sweep with bullish sentiment. It expires in 72 day(s) on January 17, 2025. Parties traded 257 contract(s) at a $65.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $31.3K, with a price of $122.0 per contract. There were 7742 open contracts at this strike prior to today, and today 3265 contract(s) were bought and sold. 
• For ZS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>), we notice a put option trade that happens to be bearish, expiring in 135 day(s) on March 21, 2025. This event was a transfer of 3125 contract(s) at a $160.00 strike. The total cost received by the writing party (or parties) was $2.2 million, with a price of $730.0 per contract. There were 1169 open contracts at this strike prior to today, and today 3125 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a call option sweep with bearish sentiment. It expires in 44 day(s) on December 20, 2024. Parties traded 1077 contract(s) at a $170.00 strike. This particular call needed to be split into 37 different trades to become filled. The total cost received by the writing party (or parties) was $146.4K, with a price of $136.0 per contract. There were 9408 open contracts at this strike prior to today, and today 2252 contract(s) were bought and sold. 
• Regarding SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we observe a call option sweep with bullish sentiment. It expires in 436 day(s) on January 16, 2026. Parties traded 300 contract(s) at a $45.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $100.3K, with a price of $335.0 per contract. There were 3384 open contracts at this strike prior to today, and today 1263 contract(s) were bought and sold. 
• For CSCO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), we notice a put option sweep that happens to be bearish, expiring in 9 day(s) on November 15, 2024. This event was a transfer of 300 contract(s) at a $57.00 strike. This particular put needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $37.2K, with a price of $124.0 per contract. There were 1687 open contracts at this strike prior to today, and today 711 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option trade that happens to be neutral, expiring in 9 day(s) on November 15, 2024. This event was a transfer of 10 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $3007.0 per contract. There were 1677 open contracts at this strike prior to today, and today 578 contract(s) were bought and sold. 
• For QCOM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), we notice a put option sweep that happens to be bullish, expiring in 9 day(s) on November 15, 2024. This event was a transfer of 105 contract(s) at a $170.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $66.1K, with a price of $630.0 per contract. There were 3344 open contracts at this strike prior to today, and today 467 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

CSCO

MARA

MSTR

NVDA

PLTR

QCOM

SMCI

10 Information Technology Stocks With Whale Alerts In Today's Session

HLIO

Helios Technologies shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

TD Cowen analyst Jason Gabelman maintains Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) with a Buy and lowers the price target from $174 to $170.

TD Cowen Maintains Buy on Marathon Petroleum, Lowers Price Target to $170

TD Cowen analyst Bill Katz maintains Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with a Buy and raises the price target from $165 to $178.

TD Cowen Maintains Buy on Apollo Global Management, Raises Price Target to $178

Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) has outperformed the market over the past 10 years by 10.33% on an annualized basis producing an average annual return of 21.51%. Currently, Adobe has a market capitalization of $221.46 billion. 
Buying $1000 In ADBE: If an investor had bought $1000 of ADBE stock 10 years ago, it would be worth $7,016.66 today based on a price of $503.09 for ADBE at the time of writing.
<h3>Adobe's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914362_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ADBE

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,000 Today

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!



Moving stocks this morning is heavy trading, drug approval, a clinical hold and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is rocketing more than 118% alongside heavy pre-market trading.</li>



<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are soaring over 54% with strong early morning trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock is surging more than 22% without any clear news on Friday morning.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) shares are increasing over 22% despite a lack of news today.</li>



<li>Geron (NASDAQ:<a href="https://investorplace.com/stock-quotes/gern-stock-quote/">GERN</a>) stock is gaining more than 21% after getting <a href="https://finance.yahoo.com/news/fda-approves-geron-rytelo-mds-082526023.html">approval for its blood disorder drug</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are rising over 16% with strong early morning trading today.</li>



<li>Braze (NASDAQ:<a href="https://investorplace.com/stock-quotes/brze-stock-quote/">BRZE</a>) stock is heading more than 15% higher alongside its <a href="https://www.nasdaq.com/press-release/braze-reports-fiscal-first-quarter-2025-results-2024-06-06">latest earnings release</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are jumping over 12% with <a href="https://investorplace.com/2024/06/short-interest-in-faraday-future-ffie-stock-falls-below-3/">falling short interest</a>.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is getting a more than 12% boost are slipping yesterday.</li>



<li>ReTo Eco-Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/reto-stock-quote/">RETO</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Biomea Fusion (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmea-stock-quote/">BMEA</a>) stock is plummeting more than 60% after <a href="https://finance.yahoo.com/news/biomea-fusion-announces-bmf-219-200500839.html">announcing a clinical hold</a>.</li>



<li>Virax Biolabs (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrax-stock-quote/">VRAX</a>) shares are diving over 20% <a href="https://investorplace.com/2024/06/why-is-virax-biolabs-vrax-stock-up-115-today/">after rallying yesterday</a>.</li>



<li>Xylo Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/xylo-stock-quote/">XYLO</a>) stock is tumbling more than 19% <a href="https://www.nasdaq.com/press-release/xylo-gix-internet-signed-mou-investment-and-merger-ai-robotics-company-2024-06-06">on merger plans</a> for a company it holds a significant stake in.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) shares are taking an over 18% beating as it continues recent negative movement.</li>



<li>Jayud Global Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jyd-stock-quote/">JYD</a>) stock is sliding more than 18% this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) shares are falling over 15% on Friday.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) stock is dropping close to 14% today.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) shares are decreasing more than 13% on Friday morning.</li>



<li>CalAmp (NASDAQ:<a href="https://investorplace.com/stock-quotes/camp-stock-quote/">CAMP</a>) stock is declining over 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318378043&amp;type=PDF&amp;symbol=CAMP&amp;cdn=15857b89629f6fd8bb5ccdef99a68bb0&amp;companyName=CalAmp+Corp.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-06">on insider selling</a>.</li>



<li>Sacks Parente Golf (NASDAQ:<a href="https://investorplace.com/stock-quotes/spgc-stock-quote/">SPGC</a>) shares close out our pre-market stock movers down more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318375423&amp;type=PDF&amp;symbol=SPGC&amp;cdn=84160401cba989fd4733d9364b53757e&amp;companyName=Sacks+Parente+Golf+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-05">on delisting woes</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-7th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the day with a breakdown of the biggest pre-market stock movers worth checking out on Tuesday morning!



Moving stocks are a share repurchase program, terminated contracts, public offerings and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock is rocketing more than 51% alongside heavy pre-market trading.</li>



<li>Blue World Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/bwaq-stock-quote/">BWAQ</a>) shares are soaring over 35% on Tuesday morning.</li>



<li>Baijiayun (NASDAQ:<a href="https://investorplace.com/stock-quotes/rtc-stock-quote/">RTC</a>) stock is surging more than 33% this morning.</li>



<li>ShiftPixy (NASDAQ:<a href="https://investorplace.com/stock-quotes/pixy-stock-quote/">PIXY</a>) shares are increasing over 31% alongside strong early morning trading.</li>



<li>QuantaSing (NASDAQ:<a href="https://investorplace.com/stock-quotes/qsg-stock-quote/">QSG</a>) stock is rising more than 24% on a <a href="https://www.nasdaq.com/press-release/quantasing-group-limited-announces-us-200-million-share-repurchase-program-2024-06-11">new share repurchase program</a>.</li>



<li>Recruiter.Com (NASDAQ:<a href="https://investorplace.com/stock-quotes/rcrt-stock-quote/">RCRT</a>) shares are gaining close to 20% on <a href="https://www.nasdaq.com/press-release/recruitercom-granted-continued-listing-nasdaq-hearings-panel-2024-06-11">continued Nasdaq listing</a>.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock is climbing over 16% today.</li>



<li>CaliberCos (NASDAQ:<a href="https://investorplace.com/stock-quotes/cwd-stock-quote/">CWD</a>) shares are jumping more than 15% on Tuesday.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is heading over 15% higher on Tuesday morning.</li>



<li>Troops (NASDAQ:<a href="https://investorplace.com/stock-quotes/troo-stock-quote/">TROO</a>) shares are up more than 15% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Target Hospitality (NASDAQ:<a href="https://investorplace.com/stock-quotes/th-stock-quote/">TH</a>) stock is plummeting more than 27% on a <a href="https://www.nasdaq.com/press-release/target-hospitality-provides-update-south-texas-family-residential-center-located">terminated service agreement</a>.</li>



<li>TCTM Kids IT Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/tctm-stock-quote/">TCTM</a>) shares are crashing over 20% despite a lack of news this morning.</li>



<li>CoreCivic (NYSE:<a href="https://investorplace.com/stock-quotes/cxw-stock-quote/">CXW</a>) stock is diving almost 19% on a <a href="https://www.nasdaq.com/press-release/corecivic-receives-termination-notice-us-immigration-and-customs-enforcement-south">terminated service agreement</a>.</li>



<li>Contango Ore (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctgo-stock-quote/">CTGO</a>) shares are tumbling more than 18% on an <a href="https://www.nasdaq.com/press-release/contango-ore-announces-underwritten-public-offering-common-stock-2024-06-10">underwritten public offering</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is taking an over 18% beating <a href="https://investorplace.com/2024/06/why-is-big-tree-cloud-dsy-stock-up-96-today/">after rallying yesterday</a>.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) shares are sliding more than 16% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318384117&amp;type=PDF&amp;symbol=SPEC&amp;cdn=2ca70fab4e23ef5d9c11557ba510b0d5&amp;companyName=Spectaire+Holdings+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-10">proposed public offering</a>.</li>



<li>Hoth Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/hoth-stock-quote/">HOTH</a>) stock is falling over 15% this morning.</li>



<li>New Horizon Aircraft (NASDAQ:<a href="https://investorplace.com/stock-quotes/hovr-stock-quote/">HOVR</a>) shares are dropping more than 15% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318385886&amp;type=PDF&amp;symbol=HOVR&amp;cdn=2118b6378708ce5dbc010cd3e0c2dc12&amp;companyName=New+Horizon+Aircraft+Ltd.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-10">plans for a public share offering</a>.</li>



<li>Yext (NYSE:<a href="https://investorplace.com/stock-quotes/yext-stock-quote/">YEXT</a>) stock is slipping over 13% alongside its <a href="https://www.benzinga.com/news/earnings/24/06/39259544/yext-stock-falls-on-q1-results-acquisition-of-hearsay-systems-the-details">latest earnings report</a>.</li>



<li>ProKidney (NASDAQ:<a href="https://investorplace.com/stock-quotes/prok-stock-quote/">PROK</a>) shares close out our pre-market stock movers down more than 13% on a <a href="https://www.marketwatch.com/story/prokidney-shares-slip-12-on-125-million-offering-aa0db3f3?mod=investing">proposed stock offering</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-11th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!



Moving stocks on Thursday are loads of earnings reports, a public stock pricing, and exclusive license deal and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is rocketing more than 68% after announcing an <a href="https://www.nasdaq.com/press-release/conduit-pharmaceuticals-enters-exclusive-license-agreement-astrazeneca-multiple">exclusive license agreement</a>.</li>



<li>Anew Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/wena-stock-quote/">WENA</a>) shares are soaring over 49% alongside heavy pre-market trading.</li>



<li>Harrow (NASDAQ:<a href="https://investorplace.com/stock-quotes/hrow-stock-quote/">HROW</a>) stock is surging more than 39% with its <a href="https://finance.yahoo.com/news/harrow-announces-second-quarter-2024-200100329.html">latest earnings report</a>.</li>



<li>1847 Holdings (NYSEMKT:<a href="https://investorplace.com/stock-quotes/efsh-stock-quote/">EFSH</a>) shares are rising over 30% despite a lack of news this morning.</li>



<li>LuxUrban Hotels (NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) stock is increasing more than 26% without any clear news today.</li>



<li>Coeptis Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/coep-stock-quote/">COEP</a>) shares are climbing over 24% on Thursday morning.</li>



<li>Aspen Aerogels (NYSE:<a href="https://investorplace.com/stock-quotes/aspn-stock-quote/">ASPN</a>) stock is heading close to 23% higher <a href="https://www.tipranks.com/news/company-announcements/aspen-aerogels-projects-financial-outlook-for-2024-2">with its new guidance</a>.</li>



<li>CompoSecure (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmpo-stock-quote/">CMPO</a>) shares are gaining more than 19% on <a href="https://au.finance.yahoo.com/news/composecure-inc-cmpo-q2-earnings-233506766.html">Q2 earnings and revenue beats</a>.</li>



<li>Digital Turbine (NASDAQ:<a href="https://investorplace.com/stock-quotes/apps-stock-quote/">APPS</a>) stock is jumping over 18% with its <a href="https://www.prnewswire.com/news-releases/digital-turbine-reports-fiscal-2025-first-quarter-financial-results-302217006.html">most recent earnings report</a>.</li>



<li>Klaviyo (NYSE:<a href="https://investorplace.com/stock-quotes/kvyo-stock-quote/">KVYO</a>) shares are up more than 18% <a href="https://www.businesswire.com/news/home/20240807687579/en/Klaviyo-Announces-Second-Quarter-2024-Financial-Results">after a guidance increase</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Cardlytics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdlx-stock-quote/">CDLX</a>) stock is crashing over 54% with its <a href="https://www.nasdaq.com/press-release/cardlytics-announces-second-quarter-2024-financial-results-2024-08-07">earnings report and a CEO change</a>.</li>



<li>Outset Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/om-stock-quote/">OM</a>) shares are plummeting more than 47% after <a href="https://finance.yahoo.com/news/outset-medical-inc-om-reports-223509136.html">missing Q2 revenue estimates</a>.</li>



<li>Bumble (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmbl-stock-quote/">BMBL</a>) stock is diving over 40% after <a href="https://www.reuters.com/technology/bumble-dives-revenue-forecast-cut-triggers-worries-over-turnaround-2024-08-08/">cutting its revenue guidance</a>.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are tumbling nearly 39% without any obvious news today.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) stock is taking a more than 36% beating <a href="https://www.nasdaq.com/press-release/greenlanes-vaporcom-named-usa-todays-list-americas-top-online-retail-shops-recent">following a recent rally</a>.</li>



<li>JFrog (NASDAQ:<a href="https://investorplace.com/stock-quotes/frog-stock-quote/">FROG</a>) shares are sliding over 26% on <a href="https://finance.yahoo.com/news/jfrog-nasdaq-frog-misses-q2-202336803.html">missed Q2 estimates</a>.</li>



<li>Dutch Bros (NYSE:<a href="https://investorplace.com/stock-quotes/bros-stock-quote/">BROS</a>) stock is dropping more than 21% <a href="https://seekingalpha.com/news/4136791-coffee-jolt-dutch-bros-gets-crushed-after-just-a-slight-miss-with-revenue-guidance">after missing estimates</a>.</li>



<li>Know Labs (NYSEMKT:<a href="https://investorplace.com/stock-quotes/knw-stock-quote/">KNW</a>) shares are decreasing over 21% after <a href="https://www.nasdaq.com/press-release/know-labs-inc-announces-pricing-3445-million-public-offering-2024-08-07">pricing a public offering</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) stock is falling more than 20% <a href="https://www.stocktitan.net/news/VTNR/vertex-energy-announces-second-quarter-2024-enonsrelirjb.html">with its Q2 earnings report</a>,</li>



<li>Fastly (NYSE:<a href="https://investorplace.com/stock-quotes/fsly-stock-quote/">FSLY</a>) shares close out our pre-market stock movers down over 19% <a href="https://www.investing.com/news/stock-market-news/fastly-shares-plunge-19-as-guidance-disappoints-despite-solid-q2-93CH-3560546">on a lackluster guidance</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-aug-8th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Viracta Therapeutics GAAP EPS of -$0.25 beats by $0.11

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!



Moving stocks this morning are earnings reports, a stock offering, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Digital Ally (NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock is rocketing more than 107% alongside heavy pre-market trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are soaring over 53% with the <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">release of its Q2 earnings report</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is surging more than 42% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318518494&amp;type=PDF&amp;symbol=CDT&amp;cdn=197541151657f71d6ed19abcc1e0e48e&amp;companyName=Conduit+Pharmaceuticals+Inc.&amp;formType=3&amp;formDescription=Initial+statement+of+beneficial+ownership+of+securities&amp;dateFiled=2024-08-13">an investment update</a>.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are rising over 26% despite a lack of news this morning.</li>



<li>Jianzhi Education Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is gaining close to 19% even with a <a href="https://www.nasdaq.com/press-release/jianzhi-education-technology-group-company-limited-receives-nasdaq-notification-0">recent delisting notice</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are increasing more than 18% on <a href="https://www.nasdaq.com/press-release/edible-garden-reports-157-increase-gross-profit-fueled-year-over-year-growth-61-cut">strong Q2 earnings</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is heading over 16% higher with its <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc-announces-unaudited-second-quarter-2024-financial-results-2024">most recent earnings report</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) shares are jumping 16% with strong early morning trading.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is climbing more than 15% with its <a href="https://www.stocktitan.net/news/SERV/serve-robotics-announces-second-quarter-2024-wqwtqr037uv4.html">Q2 earnings report</a>.</li>



<li>Kamada (NASDAQ:<a href="https://investorplace.com/stock-quotes/kmda-stock-quote/">KMDA</a>) shares are up over 15% after posting <a href="https://www.nasdaq.com/press-release/kamada-reports-strong-second-quarter-and-first-half-2024-financial-results-year-over">positive Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is crashing more than 42% after <a href="https://www.nasdaq.com/press-release/tc-biopharm-announces-pricing-20-registered-direct-offering-2024-08-13">pricing a registered direct offering</a>.</li>



<li>Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) shares are plummeting over 26% after <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">reporting a Q2 loss</a>.</li>



<li>Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) stock is diving more than 16% after <a href="https://markets.businessinsider.com/news/stocks/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024-1033684150">missing Q2 EPS estimates</a>.</li>



<li>Ouster (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/">OUST</a>) shares are taking an over 16% beating on <a href="https://www.businesswire.com/news/home/20240813944318/en/Ouster-Reports-Strong-Revenue-and-Margins-for-Second-Quarter-2024">mixed Q2 earnings</a>.</li>



<li>QuickLogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/quik-stock-quote/">QUIK</a>) stock is tumbling more than 16% with its <a href="https://www.prnewswire.com/news-releases/quicklogic-reports-41-year-over-year-revenue-growth-for-second-quarter-fiscal-2024-302221555.html">latest earnings release</a>.</li>



<li>Brinker International (NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) shares are sliding over 16% after <a href="https://www.investing.com/news/stock-market-news/brinker-international-stock-tumbles-13-on-q4-earnings-miss-93CH-3570960">posting an earnings miss</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is falling more than 15% after <a href="https://www.stocktitan.net/news/PRTG/portage-biotech-announces-1-for-20-reverse-stock-sficaewojjpr.html">announcing a reverse stock split</a>.</li>



<li>Global E Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/glbe-stock-quote/">GLBE</a>) shares are decreasing over 14% with its <a href="https://www.stocktitan.net/news/GLBE/global-e-reports-second-quarter-2024-1dq5hcfetvn1.html">Q2 earnings report</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 14% without any clear news this morning.</li>



<li>WISeKey (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkey-stock-quote/">WKEY</a>) shares close out our pre-market stock movers down nearly 14% on a <a href="https://www.nasdaq.com/press-release/sealcoin-secures-50-million-investment-commitment-gem-digital-limited-through-0">new investment</a> <a href="https://www.nasdaq.com/press-release/wisekey-partners-venafi-post-quantum-encryption-services-2024-08-14">and partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Viracta jumps after corporate update

An announcement from Viracta Therapeutics (VIRX) is now available. On August 14, 2024, the Company made headlines with a press release detailing si...

Viracta Therapeutics Announces Key Business Developments

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Viracta Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock is heading higher on Wednesday after the clinical-stage precision oncology company released its <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">Q2 earnings report</a>.



The first bit of news boosting VIRX stock higher is its diluted earnings per share of -25 cents. That&rsquo;s better than the -37 cents per share Wall Street was predicting. It&rsquo;s also an improvement over the company&rsquo;s EPS of -32 cents from the same period of the year prior.



Viracta Therapeutics notes that the improvement in its EPS comes from a $5 million of other income. This is related to the monetization of a pre-commercialization, event-based milestone from Day One Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/dawn-stock-quote/">DAWN</a>).



<h2>Updates for VIRX Stock Investors</h2>



The latest earnings report also includes business updates for investors. That includes Michael Faerm joining the company as its Chief Financial Officer.



Another bit of news from the earnings report includes the company switching focus to its more advanced EBV+ lymphoma. This has it pausing its EBV+ solid tumor program. As a result of this, the company has laid off 23% of its workforce.



VIRX stock is up 41.7% as of Wednesday morning. That comes with more than 9 million shares changing hands. This is above its daily average trading volume of about 112,000 shares.



Investors will want to stick around for even more of the most recent stock market stories today!



We have all of the latest stock market news traders need to know about on Wednesday! Among that is what has shares of Digital Ally&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock up, the biggest pre-market stock movers this morning and more. All of this info is ready to go at the links below!



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-digital-ally-dgly-stock-up-82-today/">Why Is Digital Ally (DGLY) Stock Up 82% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Wednesday</a></li>



<li><a href="https://investorplace.com/2024/08/cisco-layoffs-2024-what-to-know-about-the-latest-job-cuts-at-csco/">Cisco Layoffs 2024: What to Know About the Latest Job Cuts at CSCO</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-viracta-therapeutics-virx-stock-up-42-today/">Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) just reported results for the second quarter of 2024.<ul><li>Viracta Therapeutics reported earnings per share of -25 cents. This was above the analyst estimate for EPS of -37 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/virx-stock-earnings-viracta-therapeutics-for-q2-of-2024/">VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024

Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August

ABUS

ALPMF

ALPMY

ANTX

APPS

ASPN

ATHA

BAYRY

BAYZF

BBIO

BMBL

BMEA

BMRN

BNOX

BROS

BRZE

BURU

BWAQ

CAMP

CDLX

CDTX

CMPO

COEP

CRBU

CRKN

CTGO

CVAC

DGLY

EDBL

EFSH

FFIE

FGEN

FRES

FROG

FSLY

GERN

GLBE

GLYC

GNLN

GOVX

HLVX

HOTH

HOVR

HROW

IBRX

INAB

KITT

KMDA

KRKR

KVYO

LUXH

LXRX

MITQ

OUST

PGEN

PIXY

PROK

PRST

PRTG

QUIK

QURE

RAPT

RCRT

RETO

RHHBY

RKDA

RLAY

RPTX

SERV

SLRN

SPEC

SPGC

SURG

TCBP

TCTM

TPHS

TROO

VERO

VIRX

VRAX

VTNR

WENA

WKEY

XYLO

YEXT

Press Releases

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

Health Care

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

General

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

Viracta Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Management

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Announces New Employment Inducement Grants

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

LENZ

ABVC BioPharma

Alzamend Neuro

Comments

Viracta Therapeutics

Viracta Therapeutics (VIRX) Opzioni

Viracta Therapeutics (NASDAQ:VIRX) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO